All In MedTech

Device Trial Radar · NCT04929470

Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss

Clinical Investigation of the Safety and Performance of HiResTM Ultra Cl HiFocusTM SlimJ Electrode (Cl-1600-05) and HiResTM Ultra 3D Cl HiFocusTM SlimJ Electrode (Cl-1601-05) (Ultra X) in Adults With Severe-to-profound Hearing Loss

Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

37

Actual

Start

Jul 6, 2021

Primary completion

Feb 5, 2026

Study completion Feb 5, 2026

Sponsor

Lead sponsor
Advanced Bionics AGNot on our public-company list
Sponsor type
Industry
First posted
Jun 18, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This is a prospective study designed to evaluate the safety and performance of the HiResTM Ultra Cl HiFocusTM SlimJ Electrode and HiResTM Ultra 3D Cl HiFocusTM SlimJ Electrode (Ultra X) under normal conditions of use as it is approved for this device. Participants receive interventions as part of routine medical care.

Conditions

  • Cochlear Hearing Loss

Interventions

  • cochlear implantationDevice

    patients receive a cochlear implantation within clinical routine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freiburger Monosyllables Score in QuietTime frame: 6 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Westfälische Wilhelms-Universität Münster

    Münster, Germany

  • HNO-Klinik Düsseldorf

    Düsseldorf, Düsseldorf, Germany

  • Unfallkrankenhaus Berlin (UKB)

    Berlin, State of Berlin, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.